Abstract: Three known and one unknown impurities in salbutamol sulphate bulk drug at level 0.1% (ranging from 0.05-0.1%) were detected by gradient reverse phase high performance liquid chromatography. These impurities were preliminarily identified by the mass number of the impurities. Different experiments were conducted and finally synthesized and characterized the known and unknown imputities.
Introduction
Salbutamol sulphate is a relatively selective 2-adrenergic agonist and is used as a bronchodilator. The chemical name of salbutamol sulfate is 1-(4-hydroxy-3hydroxymeth ylphenyl)-2-(tert-butylamino) ethanol sulfate (2:1) (salt) salbutamol sulfate is indicated for the prevention and relief of bronchospasm with reversible obstructive airway disease (asthma) and for the prevention of exercise induced bronchospasm. It is also indicated for the management of acute attacks of bronchospasm. Salbutamol sulfate acts by stimulating the adenyl cyclase enzyme, which catalyzes the formation of cyclic-3,5-adenosine monophosphate (cyclic AMP) from adenosine triphosphate (ATP) [1] [2] .
There are several process impurities/related substances associated with the manufacture of salbutamol sulfate. Different process related impurities have been observed with various synthetic routes and/or manufacturing processes. Ten of the known salbutamol related substances have been mentioned in Europian Pharmacopoeia 6.0 3 . All these impurities are never present together while we are preparing bulk drug or preparing formulation.
The Europian Pharmacopoeia 3 specifies that individual impurity is not more than 0.3% and total impurity is not more than 1.0%. The British Pharmacopoeia 4 specifies that the related impurities which is determined by TLC, to be maximum of 0.5%. The united states pharmacopoeia 5 requires that the sum of the impurities in salbutamol sulphate should not be greater than 2.0%.
During the process development of salbutamol sulphate three known and one unknown impurities were identified in the analysis of different batches whose percent area ranged from 0.05-0.1% by HPLC [3] [4] [5] . A comprehensive study has been carried out to isolate or to prepare and characterize these impurities. To the best of our knowledge, synthesis rout of impurities is novel and not reported in literature. Due to the importance of regulatory authorities 6 and all the impurities should be at the level of >0.1% must identify and characterized.
A literature search revealed that only analytical procedure 7-9 is available but nobody has reported synthesis, isolation and characterization of impurities in the purified form starting from salbutamol sulphate. The present communication involves the isolation or preparation of impurities and characterized by chromatographic and spectroscopic techniques 10 .
Experimental
The investigated samples of bulk salbutamol sulphate were received from Pharmasolve Specialities (I) Pvt. Ltd. Mumbai.
High performance liquid chromatography (HPLC)
An in-house LC method was developed for the reaction monitoring of salbutamol impurities. A Shimadzu model LC2010CHT equipped with a UV detector was used. The chromatographic condition optimized were ODS, 50×4. 
Mass spectrometry
Electrospray ionization mass spectroscopy was performed using an ion trap mass spectrometer (Model 6310 agilent). The positive and negative electrospray MS data was obtained by switching the capillary voltage between n+ 5000 and -4500V respectively.
NMR spectroscopy
The NMR experiments were performed on Bruker avance II 400 MHz .The 1 H chemical shift values were reported on the δ scale in ppm, relative to TMS (δ=0.00) and the 13 C chemical shift values were reported relative to CDCl 3 (δ=77.00 ppm) and DMSO, d6 (δ=39.50 ppm)as internal standards.
1 H and 13 C experiment was run using a mixing time of 1000 ns.
FT-IR spectroscopy
The IR spectra were recorded in the solid state as KBr dispersion medium using Perkin Elmer spectrum 100 FT-IR spectrophotometer.
Synthesis of impurities

Synthesis of impurity 1, 2 and 3
Salbutamol base (2 g) was charged into one neck round bottom flask with magnetic stirrer. Methanol (50 mL) was added and stirring was started. NaOH (2 g) was added very slowly and again methanol (50 mL) was introduced to dissolve the base completely. The contents were stirred slowly with heating. The samples were checked using HPLC. The HPLC analysis showed 3 peaks separately which confirm the presence of three different impurities. The peaks were purified using preparative HPLC and marked as fraction-1, 2 and 3 (Scheme 1). 
Synthesis of impurity 4
Salbutamol base 2 g was charged with 50 mL acetone into one neck round bottom flask with magnatic stirrer K 2 CO 3 (1.2 g) was added and heating started with stirring. To this benzylchloride 1.1 g was added and contents refluxed for 12 h. After 12 h the reaction mass was checked using HPLC. The HPLC analysis showed 1 peak separately which confirm the presence of one different impurity. This peak was purified using preparative HPLC and marked as fraction-4 (Scheme 2). 
Results and Discussion
Structure elucidation of impurity 1(Impurity-1)
Sample was analyzed by HPLC and its purity was found to be 93.14%, molecular weight of salbutamol sulphate impurity-1 is 253.34 which is 14 mass unit higher than that of salbutamol sulphate. The ESI mass spectrum of sample gave a protonated molecular ion at m/z 254.1 and deprotonated molecular ion at m/z 252.6 which is the same as salbutamol sulphate impurity-1 Impurity 3 Impurity 4 Scheme 3.
1 H NMR assignment of impurities 1,2,3 & 4
Structure elucidation of impurity 2(Impurity-2)
Sample was analyzed by HPLC and its purity was found to be 87.93%, molecular weight of salbutamol sulphate impurity-2 is 460.62 which is 221 mass unit higher than that of salbutamol sulphate. The ESI mass spectrum of sample gave a protonated molecular ion at m/z 461.3 and deprotonated molecular ion at m/z 459.5 which is the same as salbutamol sulphate impurity-2, IR spectrum displayed characteristic absorptions at 3420. 
Structure elucidation of impurity 3(Unknown impurity)
Sample was analyzed by HPLC and its purity was found to be 96.72%, molecular weight of salbutamol sulphate impurity-3 is 251.37 which is 12 mass unit higher than that of salbutamol sulphate. The ESI mass spectrum of sample gave a protonated molecular ion at m/z 252.1 and deprotonated molecular ion at m/z 250.6.which confirm that molecular weight is 251. 
Conclusion
This research paper describes the synthesis, isolation and structure elucidation of process related impurities in salbutamol sulphate. The impurities were separated by reverse phase chromatographic technique, further isolated by semipreparative liquid chromatography. The isolated impurities were characterized using spectroscopic techniques. This isolated impurities were used for mass balance of salbutamol sulphate technical material. The synthesis of impurities was also discussed in brief.
